Pine Labs delivered a strong market debut, listing at a 9.5% premium and rallying further to give IPO investors gains of nearly 30% from the IPO price. Brokerages remain positive on the company’s long-term prospects but advise allotted investors to hold.
Kaynes shares plunge 43% from October peak. Is a tactical rebound on the cards or more pain ahead?
Kaynes has plunged 43.5% from its October peak, with Friday’s 12.5% drop marking the steepest single-day decline. Momentum indicators remain bearish, signaling a risk of